Antidepressant use during pregnancy benefits mothers with pre‐existing depression
The Brown University Psychopharmacology Update · 2026-12 · 37 (12) · 2-2
DOI: 10.1002/pu.31519 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Brown University Psychopharmacology Update, online erschienen am 14.11.2026. Verfasst von Y. W. Francis Lam. Die Arbeit nennt 2 Literaturangaben.
Themen: Depression
Abstract (Originalsprache)
Despite general concern regarding medication safety with potential teratogenic risk during pregnancy, antidepressant use during pregnancy is recommended by obstetric and psychiatric professional societies in selected patients with a history of depressive disorder (1). Depressive symptoms in periconception (before and immediately following conception) can have an adverse effect on the mother, affecting proper diet intake, normal sleep pattern, and general maternal health. Potential negative outcomes can also impact the child, including preterm birth and low birth weight. Maternal depression can decrease breastfeeding initiation and maternal‐infant bonding, as well as increase the risk of suicide.
Zitieren
APA
Lam, Y. W. F. (2026). Antidepressant use during pregnancy benefits mothers with pre‐existing depression. The Brown University Psychopharmacology Update, 37(12), 2-2. https://doi.org/10.1002/pu.31519
Vancouver
Lam YWF. Antidepressant use during pregnancy benefits mothers with pre‐existing depression. The Brown University Psychopharmacology Update. 2026;37(12):2-2. doi:10.1002/pu.31519
BibTeX
@article{Lam2026,
author = {Lam, Y. W. Francis},
title = {Antidepressant use during pregnancy benefits mothers with pre‐existing depression},
journal = {The Brown University Psychopharmacology Update},
year = {2026},
volume = {37},
number = {12},
pages = {2--2},
doi = {10.1002/pu.31519}
}
EUVIMED